1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Cohort demographics
Demographics
No. of patients137
No. of PED treatments148
Average patient age (yr)54.7
% Male per treatment6.6%
No. of aneurysms treated178
Average aneurysm size (mm)5.2
% Aneurysms treated acutely/subacutely after rupture3.3%
% Aneurysms with branch vessel incorporation35%
Mean No. of PEDs per treatment1.07
% Aneurysms adjunctively coiled9.2%
% Treatments using J-tip microcatheter17%
% Treatments using balloon angioplasty6.1%
% Treatments requiring abciximab4.8%
Mean length of DSA follow-up (mo)18.4